telmisartan has been researched along with Retinal Neovascularization in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, E; Inoue, M; Ishida, S; Koto, T; Kubota, Y; Nagai, N; Noda, K; Oike, Y; Shinoda, H; Shinoda, K; Shiomi, T; Suda, T; Tsubota, K; Urano, T | 1 |
1 other study(ies) available for telmisartan and Retinal Neovascularization
| Article | Year |
|---|---|
Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Benzimidazoles; Benzoates; Enzyme-Linked Immunosorbent Assay; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Ischemia; Mice; Mice, Inbred BALB C; Neovascularization, Physiologic; Receptor, Angiotensin, Type 1; Retinal Neovascularization; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2005 |